Clinton Weber

Company: Umoja Biopharma

Job title: Vice President, CMC Strategy

Seminars:

Industry Leaders Fireside Chat: Evaluating CAR-T in Comparison to Emerging Modalities to Refine Autoimmune Therapies Through Strategic Modality Selection 8:40 am

Explore the efficacy of differing modalities to identify opportunities where we can learn from other modalities Compare modalities in their affinity for targeting autoreactive cells to minimize side-effects and enhance safety Identify autoimmune indications where CD-19-CARs are suboptimal to spotlight opportunities for alternative therapeutic modalitiesRead more

day: Conference Day 1 P1